{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:47:15Z","timestamp":1768884435381,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijcard.2016.08.318","type":"journal-article","created":{"date-parts":[[2016,8,28]],"date-time":"2016-08-28T11:15:12Z","timestamp":1472382912000},"page":"863-866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Association of cardiac cachexia and atrial fibrillation in heart failure patients"],"prefix":"10.1016","volume":"223","author":[{"given":"Estefan\u00eda","family":"Ar\u00e1mbula-Garza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Castillo-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulce","family":"Gonz\u00e1lez-Islas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Orea-Tejeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Santellano-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candace","family":"Keirns-Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viridiana","family":"Pel\u00e1ez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"S\u00e1nchez-Santill\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Pineda-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cintora-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Pablo-Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijcard.2016.08.318_bb0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0148607114566854","article-title":"Malnutrition and cachexia in heart failure","volume":"40","author":"Rahman","year":"2016","journal-title":"J. Parenter. Enter. Nutr."},{"issue":"6","key":"10.1016\/j.ijcard.2016.08.318_bb0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.ijcard.2016.08.318_bb0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.ijcard.2016.08.318_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-014-0137-y","article-title":"Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist","volume":"5","author":"Kazemi-Bajestani","year":"2014","journal-title":"J Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2016.08.318_bb0025","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ijcard.2016.08.318_bb0030","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s40265-015-0452-4","article-title":"Direct oral anticoagulants for the prevention of stroke in patients with nonvalvular atrial fibrillation: understanding differences and similarities","volume":"75","author":"Dobesh","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2016.08.318_bb0035","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2016.08.318_bb0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejheart.2006.01.015","article-title":"Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF study","volume":"8","author":"van Veldhuisen","year":"2006","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcard.2016.08.318_bb0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejheart.2006.10.021","article-title":"Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the alpha study registry","volume":"9","author":"De Ferrari","year":"2007","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2016.08.318_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (seniors)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur. Heart J."},{"issue":"9377","key":"10.1016\/j.ijcard.2016.08.318_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial (COMET): randomized controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijcard.2016.08.318_bb0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejheart.2006.08.004","article-title":"Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction","volume":"9","author":"Corell","year":"2007","journal-title":"Eur. J. Heart Fail."},{"issue":"10","key":"10.1016\/j.ijcard.2016.08.318_bb0065","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (charm) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.ijcard.2016.08.318_bb0070","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/01.CIR.98.23.2574","volume":"98","author":"Deedwania","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2016.08.318_bb0075","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2004.09.033","article-title":"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the valsartan heart failure trial (val-heft)","volume":"149","author":"Maggioni","year":"2005","journal-title":"Am. Heart J."},{"issue":"13","key":"10.1016\/j.ijcard.2016.08.318_bb0080","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/eurheartj\/ehi166","article-title":"Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.08.318_bb0085","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0735-1097(02)02373-2","article-title":"Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women","volume":"40","author":"Tsang","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2016.08.318_bb0090","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(98)00297-6","volume":"32","author":"Dries","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2016.08.318_bb0095","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham heart study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.08.318_bb0100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2016.08.318_bb0105","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/eurheartj\/ehi166","article-title":"Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.08.318_bb0110","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"issue":"4 Suppl A","key":"10.1016\/j.ijcard.2016.08.318_bb0115","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The epidemiology of heart failure: the Framingham study","volume":"22","author":"Ho","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.ijcard.2016.08.318_bb0120","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"8A","key":"10.1016\/j.ijcard.2016.08.318_bb0125","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.08.318_bb0130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.STR.28.2.316","article-title":"Atrial fibrillation and dementia in a population-based study. The Rotterdam study","volume":"28","author":"Ott","year":"1997","journal-title":"Stroke"},{"issue":"8A","key":"10.1016\/j.ijcard.2016.08.318_bb0135","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.08.318_bb0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jcpt.12122","article-title":"Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions","volume":"39","author":"Cheng","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"issue":"23","key":"10.1016\/j.ijcard.2016.08.318_bb0145","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2016.08.318_bb0150","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCOUTCOMES.112.965988","article-title":"Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation","volume":"5","author":"Schneeweiss","year":"2012","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"10","key":"10.1016\/j.ijcard.2016.08.318_bb0155","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1185\/030079905X65475","article-title":"Economic burden and co-morbidities of atrial fibrillation in a privately insured population","volume":"21","author":"Wu","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"16","key":"10.1016\/j.ijcard.2016.08.318_bb0160","first-page":"2003","article-title":"ACCF\/AHA guidelines for the Management of Heart Failure","volume":"62","author":"Jessup","year":"2013","journal-title":"JACC"},{"key":"10.1016\/j.ijcard.2016.08.318_bb0165","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijcard.2014.10.003","article-title":"Frequency and Clinical Characteristics of Acute Heart Failure Patients at INCMNSZ, Mexico City, Mexico","volume":"177","author":"P\u00e9rez Flores","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2016.08.318_bb0170","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ajcn\/41.4.810","article-title":"Assessment of fat-free mass using bioelectrical impedance measurements of the human body","volume":"41","author":"Lukaski","year":"1985","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.ijcard.2016.08.318_bb0175","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.1994.305","article-title":"A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph","volume":"46","author":"Piccoli","year":"1994","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.ijcard.2016.08.318_bb0180","first-page":"15","article-title":"Vectores de impedancia bioelectrica para la composici\u00f3n corporal en poblaci\u00f3n mexicana","volume":"59","author":"Espinosa","year":"2007","journal-title":"Rev. Investig. Clin."},{"issue":"3","key":"10.1016\/j.ijcard.2016.08.318_bb0185","first-page":"228","article-title":"An\u00e1lisis convencional y vectorial de bioimpedancia en la pr\u00e1ctica cl\u00ednica","volume":"22","author":"Piccoli","year":"2002","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.ijcard.2016.08.318_bb0190","series-title":"BIVA Software. Department of Medical and Surgical Sciences","author":"Piccoli","year":"2002"},{"key":"10.1016\/j.ijcard.2016.08.318_bb0195","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.08.318_bb0200","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjmed.2009.06.033","article-title":"Atrial fibrillation in heart failure: a comprehensive review","volume":"123","author":"Deedwania","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2016.08.318_bb0205","first-page":"3250","article-title":"Atrial fibrillation in heart failure: what should we do?","volume":"36","author":"Kotecha","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.08.318_bb0210","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/hc4601.099402","article-title":"Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure","volume":"104","author":"Li","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.08.318_bb0215","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.RES.85.5.473","article-title":"Ionic determinants of atrial fibrillation and Ca2+ channel abnormalities: cause, consequence, or innocent bystander?","volume":"85","author":"Nattel","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.08.318_bb0220","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"issue":"suppl","key":"10.1016\/j.ijcard.2016.08.318_bb0225","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2016.08.318_bb0230","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/07853890410017467","article-title":"Cardiac cachexia","volume":"36","author":"Anker","year":"2004","journal-title":"Ann. Med."},{"key":"10.1016\/j.ijcard.2016.08.318_bb0235","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by renin-angiotensin system inhibition. A meta-analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.318_bb0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2012.02.009","article-title":"Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials","volume":"165","author":"Khatib","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.318_bb0245","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2005.06.036","article-title":"Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program","volume":"152","author":"Ducharme","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2016.08.318_bb0250","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Beta blockers in heart failure collaborative group. Efficacy of beta blockers in patients with heart failure plus atrial fibrillation:an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.08.318_bb0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijcard.2013.11.001","article-title":"A statement on ethical standards in publishing scientific articles in the international journal of cardiology family of journals","volume":"170","author":"Shewan","year":"2014","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316320320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316320320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T03:59:28Z","timestamp":1553313568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316320320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":51,"alternative-id":["S0167527316320320"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.318","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of cardiac cachexia and atrial fibrillation in heart failure patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}